Position history for CITADEL ADVISORS LLC's holdings in ENLIVEN THERAPEUTICS INC
CITADEL ADVISORS LLC holds 1.7M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $68.4M as of 2026-Q1. The position was increased (+22.4% shares). ELVN represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$68.4M
Current Shares
1.7M
Total Value Change
+$14.4M
Total Shares Change
-563,899
Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc
Increased |
| 1.7M |
+22.4% |
| $68.4M |
| 0.0% |
| $28.75 |
36 |
| 2025-Q4 | Increased | 1.4M | +22.7% | $21.9M | 0.0% | $15.55 | 34 |
| 2025-Q3 | Decreased | 1.2M | -21.1% | $23.8M | 0.0% | $20.30 | 0 |
| 2025-Q2 | Increased | 1.5M | +30.9% | $29.5M | 0.0% | $20.68 | 36 |
| 2025-Q1 | Decreased | 1.1M | -35.4% | $22.1M | 0.0% | $21.07 | 0 |
| 2024-Q4 | Increased | 1.7M | +0.3% | $39.1M | 0.0% | $22.39 | 29 |
| 2024-Q3 | Decreased | 1.7M | -24.9% | $44.3M | 0.0% | $24.13 | 0 |
| 2024-Q2 | Decreased | 2.3M | -2.0% | $53.9M | 0.0% | $23.37 | 0 |